Ramm Pharma Corp Stock Z Score
RAMMFDelisted Stock | USD 0.06 0.00 0.00% |
RAMM |
RAMM Pharma Corp Company Z Score Analysis
RAMM Pharma's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionBased on the company's disclosures, RAMM Pharma Corp has a Z Score of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The z score for all United States stocks is 100.0% higher than that of the company.
RAMM Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RAMM Pharma's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of RAMM Pharma could also be used in its relative valuation, which is a method of valuing RAMM Pharma by comparing valuation metrics of similar companies.RAMM Pharma is currently under evaluation in z score category among its peers.
RAMM Fundamentals
Return On Equity | -0.12 | |||
Return On Asset | -0.0789 | |||
Profit Margin | (1.76) % | |||
Operating Margin | (1.89) % | |||
Current Valuation | 1.85 M | |||
Shares Outstanding | 122.4 M | |||
Shares Owned By Insiders | 34.88 % | |||
Shares Owned By Institutions | 0.89 % | |||
Price To Book | 0.18 X | |||
Price To Sales | 4.04 X | |||
Revenue | 4.12 M | |||
Gross Profit | (37.32 K) | |||
EBITDA | (6.36 M) | |||
Net Income | (7.11 M) | |||
Cash And Equivalents | 12.79 M | |||
Cash Per Share | 0.10 X | |||
Total Debt | 8.69 K | |||
Current Ratio | 9.18 X | |||
Book Value Per Share | 0.41 X | |||
Cash Flow From Operations | (3.82 M) | |||
Earnings Per Share | (0.05) X | |||
Beta | -0.75 | |||
Market Capitalization | 15.16 M | |||
Total Asset | 59.71 M | |||
Net Asset | 59.71 M |
About RAMM Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RAMM Pharma Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RAMM Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RAMM Pharma Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in RAMM Pink Sheet
If you are still planning to invest in RAMM Pharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RAMM Pharma's history and understand the potential risks before investing.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |